Literature DB >> 24210447

Positron emission tomography-computed tomography imaging for malignancies in women.

Chitra Viswanathan1, Priya R Bhosale, Shetal N Shah, Raghunandan Vikram.   

Abstract

The role of Positron Emission Tomography/Computed Tomography (PET/CT) in the evaluation of various gynecologic malignancies in light of current available data is presented and illustrated with imaging examples, pearls, and common pitfalls. 18F-fluorodeoxyglucose PET/CT is being increasingly used in management of gynecologic malignancy and has useful applications in cervical, ovarian, and endometrial carcinoma. Sensitivity and specificity are superior compared with conventional imaging. However, there are limitations of which the reporting physician should be aware. This article introduces the available evidence and discusses the role of PET/CT in various gynecologic malignancies and highlights imaging pearls and potential pitfalls.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Endometrial cancer; Gynecologic malignancy; PET/CT; Pitfalls

Mesh:

Substances:

Year:  2013        PMID: 24210447     DOI: 10.1016/j.rcl.2013.07.006

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  4 in total

1.  Unusual presentation of metastatic ovarian carcinoma as an enlarged intramammary lymph node.

Authors:  Callan Mason; Kendall Yokubaitis; Raynal Hamilton; Umesh Oza; Zeeshan Shah; Joseph Spigel; Jean Wang
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-07

Review 2.  Positron emission tomography image-guided drug delivery: current status and future perspectives.

Authors:  Rubel Chakravarty; Hao Hong; Weibo Cai
Journal:  Mol Pharm       Date:  2014-06-04       Impact factor: 4.939

3.  Construction and Evaluation of the Tumor-Targeting, Cell-Penetrating Multifunctional Molecular Probe iCREKA.

Authors:  Li-Juan Wang; Hong-Sheng Li; Quan-Shi Wang; Hu-Bing Wu; Yan-Jiang Han; Wen-Lan Zhou; Meng Wang; Shun Huang
Journal:  Contrast Media Mol Imaging       Date:  2018-03-04       Impact factor: 3.161

4.  Assessment of Lymph Node Involvement with PET-CT in Advanced Epithelial Ovarian Cancer. A FRANCOGYN Group Study.

Authors:  Antoine Tardieu; Lobna Ouldamer; François Margueritte; Lauranne Rossard; Aymeline Lacorre; Nicolas Bourdel; Guillaume Lades; Camille Sallée; Jacques Monteil; Tristan Gauthier
Journal:  J Clin Med       Date:  2021-02-05       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.